NCT03068260View on ClinicalTrials.gov

Ultrasound-guided Transmuscular Quadratus Lumborum Block for Elective Caesarean Section.

PHASE4CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

March 15, 2017

Primary Completion Date

December 1, 2017

Study Completion Date

December 1, 2017

Conditions
Postoperative Pain
Interventions
DRUG

Ropivacaine

30 ml ropivacaine 0,375% administered on each side as bilateral TQL blocks

DRUG

Saline

30 ml saline 0,375% administered on each side as bilateral TQL blocks

DRUG

Acetaminophen

1 g orally administered postoperatively

DRUG

Ibuprofen 400Mg Tablet / Celebra 100 Mg tablet

orally administered postoperatively

DEVICE

ultrasound-guided nerve block

Transmuscular quadratus lumborum block, ultrasound-guided

DRUG

Morphine

intravenously administered morphine via PCA-pump

DEVICE

Patient-controlled analgesia

PCA-pump with IV-Morphine. 5 mg administered per bolus. Lock-out time and max. dosage standardized.

Trial Locations (1)

4000

ZUH, Roskilde

All Listed Sponsors
lead

Zealand University Hospital

OTHER

NCT03068260 - Ultrasound-guided Transmuscular Quadratus Lumborum Block for Elective Caesarean Section. | Biotech Hunter | Biotech Hunter